Literature DB >> 4969551

Clinical evaluation of verapamil in angina pectoris.

G Sandler, G A Clayton, S G Thornicroft.   

Abstract

A controlled double-blind study of verapamil in 16 anginal patients used two dose levels-40 mg. t.d.s. and 120 mg. t.d.s.-and was compared with propranolol 100 mg. t.d.s. At the higher dosage verapamil produced a significant improvement in frequency of angina, trinitrin consumption, and exercise tolerance, and had a favourable and significant effect on the amount and duration of ischaemic S-T depression occurring in the electrocardiogram during exercise. In the lower dose verapamil produced significant subjective improvement but no objective benefit in the electrocardiogram. No significant differences were found between the favourable results with the higher dosage of verapamil and propranolol.The action of verapamil is not fully understood, but its favourable effects in angina may be due to a direct action on the myocardium, possibly with accompanying coronary vasodilatation.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4969551      PMCID: PMC1986217          DOI: 10.1136/bmj.3.5612.224

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  30 in total

1.  Propranolol in the treatment of angina pectoris.

Authors:  J Frieden
Journal:  Am Heart J       Date:  1967-09       Impact factor: 4.749

2.  Thromboembolism and oestrogen therapy.

Authors:  J C Bailar
Journal:  Lancet       Date:  1967-09-09       Impact factor: 79.321

3.  Beta-adrenergic blockade in angina pectoris: a method of treadmill assessment.

Authors:  D A Birkett; D A Chamberlain
Journal:  Br Med J       Date:  1966-08-27

4.  Is verapamil a beta-blocker?

Authors:  R H Grant; D G McDeritt; R G Shanks
Journal:  Lancet       Date:  1968-02-17       Impact factor: 79.321

5.  Double blind evaluation of orally administered iproveratril in patients with angina pectoris.

Authors:  M Neumann; A A Luisada
Journal:  Am J Med Sci       Date:  1966-05       Impact factor: 2.378

6.  Multicenter trial of propranolol in angina pectoris.

Authors:  R H Grant; P Keelan; R J Kernohan; J C Leonard; L Nancekievill; K Sinclair
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

7.  Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium.

Authors:  E D Luebs; A Cohen; E J Zaleski; R J Bing
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

8.  Comparison of radiocardiography and conventional electrocardiography in the exercise tolerance test.

Authors:  G Sandler
Journal:  Br Heart J       Date:  1967-09

9.  Effects of propranolol on exercise tolerance in angina pectoris.

Authors:  J Hamer; E Sowton
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

10.  Coronary cineangiographic study of intravenously administered isoptin.

Authors:  J D Mignault
Journal:  Can Med Assoc J       Date:  1966-12-10       Impact factor: 8.262

View more
  30 in total

1.  Reduction of the size of acute, experimental myocardial infarction by Verapamil.

Authors:  W Wende; W Bleifeld; J Meyer; H W Stühlen
Journal:  Basic Res Cardiol       Date:  1975 Mar-Apr       Impact factor: 17.165

2.  Calcium antagonists: A new class of therapeutic agents.

Authors:  Antonius Gunawan; Ali Massumi; Robert J. Hall
Journal:  Cardiovasc Dis       Date:  1981-09

3.  Verapamil in ischaemic heart disease--quantitative assessment by serial multistage treadmill exercise.

Authors:  V Balasubramanian; P K Khanna; G R Naryanan; R S Hoon
Journal:  Postgrad Med J       Date:  1976-03       Impact factor: 2.401

4.  Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.

Authors:  M Picca; F Azzollini; A Cereda; G Pelosi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Clinical evaluation of oxprenolol in angina pectoris.

Authors:  G Sandler; A Pistevos
Journal:  Br Heart J       Date:  1972-08

Review 6.  Verapamil and the myocardium.

Authors:  W G Nayler; D Krikler
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

7.  Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.

Authors:  G Sandler; G A Clayton
Journal:  Br Med J       Date:  1970-05-16

8.  Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.

Authors:  A G Wilson; O G Brooke; H J Lloyd; B F Robinson
Journal:  Br Med J       Date:  1969-11-15

Review 9.  Verapamil in arrhythmia.

Authors:  D M Krikler
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 10.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.